STOCK TITAN
  1. Home
  2. Sec-filings
  3. ALRTF
  4. [6-K] ALR Technologies SG Ltd. Current Report (Foreign Issuer)

ALR Technologies SG (ALRTF) signs Letter of Intent to acquire CGM Medical units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

ALR Technologies SG Ltd. filed a Form 6-K stating it has issued a press release about a planned acquisition. The company entered into a Letter of Intent to acquire CGM Medical Technology Singapore Pte. Ltd. and CGM Medical Technology Shenzhen Ltd., signaling a potential expansion of its medical technology operations.

Positive

  • None.

Negative

  • None.

Insights

ALR outlines a non-binding step toward acquiring two CGM Medical entities.

ALR Technologies SG Ltd. has disclosed a Letter of Intent to acquire CGM Medical Technology Singapore Pte. Ltd. and CGM Medical Technology Shenzhen Ltd. A Letter of Intent typically sets key terms and indicates serious interest but is often non-binding.

The filing does not provide deal value, structure, or closing conditions, so the economic impact cannot be assessed from this excerpt. Future, more detailed agreements and regulatory or corporate approvals, if any are required, will determine whether the transaction proceeds and how it affects ALR’s scale and strategy.

Form 6-K regulatory
"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.
foreign private issuer regulatory
"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
Letter of Intent financial
"Press Release dated June 30, 2026, Announcing the Company entering into a Letter of Intent to acquire"
A letter of intent is a document that shows an agreement in principle between parties to work towards a future deal or transaction. It outlines their intentions and key terms, acting like a roadmap before a formal contract is signed. For investors, it signals serious interest and helps clarify expectations early in the process.
Exhibit 99.1 regulatory
"a copy of which is furnished as Exhibit 99.1 to this Report on Form 6-K"
Exhibit 99.1 is a label used in regulatory filings to identify a specific attached document, most often a company press release or investor presentation filed with securities regulators. For investors it matters because it marks an official, contemporaneous source of information directly tied to a filing—like the original news article pinned to a legal record—so traders and analysts treat it as an authoritative statement that can move a stock or clarify a company’s situation.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

____________________

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of June 2026

 

____________________       

 

Commission File Number: 000-56491

 

ALR Technologies SG Ltd.

(Translation of registrant’s name into English)

 

 

9 Raffles Place

#26-01 Republic Plaza

Singapore

Singapore 048619

(Address of principal executive office)

____________________

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

 

 

CONTENTS

 

On June 30, 2026, ALR Technologies SG Ltd. (the “Company”) issued a press release, a copy of which is furnished as Exhibit 99.1 to this Report on Form 6-K and incorporated by reference herein.

 

Exhibit Number Description of Exhibit
99.1 Press Release dated June 30, 2026, Announcing the Company entering into a Letter of Intent to acquire CGM Medical Technology Singapore Pte. Ltd. and CGM Medical Technology Shenzhen Ltd.

 

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undesigned, thereunto duly authorized.

 

Date: June 30, 2026

 

 

ALR Technologies SG Ltd.

 

By: s/ Sidney Chan

Name: Sidney Chan

Title: CEO

 

 

 

 

Exhibit 99.1

 

 

 

 

 

 

 

 

 

Source: View Original Filing on SEC EDGAR

FAQ

What did ALR Technologies SG Ltd. (ALRTF) announce in its June 2026 Form 6-K?

ALR Technologies SG Ltd. reported that it issued a press release announcing a Letter of Intent to acquire CGM Medical Technology Singapore Pte. Ltd. and CGM Medical Technology Shenzhen Ltd., indicating plans for a potential expansion in the medical technology sector.

Which companies is ALR Technologies SG Ltd. (ALRTF) planning to acquire?

ALR Technologies SG Ltd. signed a Letter of Intent to acquire CGM Medical Technology Singapore Pte. Ltd. and CGM Medical Technology Shenzhen Ltd. These entities are referenced together in a press release furnished as Exhibit 99.1 to the company’s June 2026 Form 6-K filing.

Is ALR Technologies SG Ltd.’s acquisition of CGM Medical Technology companies finalized?

The acquisition is not finalized; ALR Technologies SG Ltd. has entered into a Letter of Intent. This indicates an agreed framework for a potential deal, but completion would depend on definitive agreements and any required approvals, which are not detailed in the provided excerpt.

Where can investors find more details on ALR Technologies SG Ltd.’s planned acquisition?

Investors can look to the press release dated June 30, 2026, furnished as Exhibit 99.1 to ALR Technologies SG Ltd.’s Form 6-K. That exhibit is incorporated by reference and is intended to provide more information on the Letter of Intent and planned transaction.

What type of SEC filing did ALR Technologies SG Ltd. (ALRTF) submit for this announcement?

ALR Technologies SG Ltd. submitted a Form 6-K, which foreign private issuers use to furnish current information. This particular Form 6-K forwards a press release about a Letter of Intent to acquire two CGM Medical Technology entities in Singapore and Shenzhen.

Filing Exhibits & Attachments

4 documents

Press Releases